Pharmaceutics - Medika Life

CATEGORIES

Pharmaceutics

Colorado Charts Its Own Course on Vaccines Amid Federal Pullback

Medika Life - May 25, 2026

Of Measles and Midterms

Richard Hatzfeld - April 29, 2026

BIO – Biotech Without Borders

Gil Bashe, Medika Life Editor - June 17, 2025

Is Getting COVID Shots in the Same Arm Better?

Michael Hunter, MD - November 8, 2023

LATEST

Alternate Health

Got Cancer? Supplements May Be Dangerous

Michael Hunter, MD - December 22, 2021

Mental Health

Three Ways I Drop Stress in the Omicron Era – A Doctor’s Approach

Michael Hunter, MD - December 21, 2021

Addiction

Oxycodone No Better in Treating Post-Orthopedic Surgical Pain

Dr. Hesham A. Hassaballa - November 24, 2021

Healthcare Policy and Opinion

Does Pharma Need Independent DNA Oversight?

Robert Turner, Founding Editor - November 22, 2021

Press Release

FINN Partners Brings Aboard the Pharmacy Podcast Network

Medika Life - November 22, 2021

Healthcare Policy and Opinion

When We Incentivize Treatment Over Outcomes, People Suffer

Gil Bashe, Medika Life Editor - October 31, 2021

General Health

Aspirin. Your Heart’s Best Friend, or Maybe Not

Medika Life - October 13, 2021

Healthcare Policy and Opinion

Advocating for Leaders in Pharmacy. Drawing Attention to Unsung Heroes

Pharmacy Podcast Network - October 7, 2021

Press Release

The 50 Most Influential Leaders in Pharmacy Awards Opens for Nominations

Medika Life - October 4, 2021

Editors Choice

Seriously, People, Just Get A COVID Vaccine

Dr. Hesham A. Hassaballa - September 17, 2021

1 234...11 Page 3 of 11

TRENDING

The Evolution of Quinine to Hydroxychloroquine, Covid’s Snake Oil

Science Duuude - June 18, 2021

Ten mRNA Facts You Probably Didn’t Know About and Ten Nonsenses

Robert Turner, Founding Editor - October 6, 2022

Ten Facts You Didn’t Know About Moderna and Their mRNA Vaccine

Robert Turner, Founding Editor - April 25, 2021

Adrenochrome, Satanic Masses, Abducted Children and Urban Legends

Robert Turner, Founding Editor - July 12, 2023

Phexxi; Have You Heard About This New Hormone-Free Contraceptive?

Dr Jeff Livingston - September 26, 2020

Killing The Coronavirus. A New Treatment Shows 99.9 Percent Efficacy

Medika Life - April 19, 2021

Ivermectin is NOT Hydroxychloroquine. Why is the FDA Ignoring a Potential Covid Treatment?

Robert Turner, Founding Editor - January 10, 2021

Kratom is an Unregulated Addictive Drug That Kills

Robert Turner, Founding Editor - December 8, 2020

Healthcare Workers Show Their Faith in the Covid Vaccine #vaccinechallenge

Medika Life - December 17, 2020

Oriahnn; A Drug to Stop Heavy Periods for Women With Fibroids

Dr Jeff Livingston - October 28, 2020

EDITORS CHOICE

Evrysdi™ Approved for Spinal Muscular Atrophy Home Treatment

Medika Life - August 8, 2020

The FDA has approved Evrysdi™ (risdiplam), the first at-home, orally administered treatment for spinal muscular atrophy in children and adults

Todd Eury, Pharmacy Podcast Network

Medika Life - February 10, 2021

Todd Eury is pharmacy is Pharmacy Podcast Network. His network enables the pharmacy sector and provides them a voice.

The Diversion of Drugs Within Healthcare Needs to be Addressed

Medika Life - September 16, 2020

The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting

It’s Time to Up Our Messaging Game Ahead of Another Winter with COVID

Richard Hatzfeld - September 23, 2023

This is not the time to roll out stale messaging delivered by a carousel of health officials trying to convince the public to get the test kits.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories